本页面由Tiger Trade Technology Pte. Ltd.提供服务

Denali Therapeutics Inc.

18.95
-0.5000-2.57%
盘前:19.040.0900+0.47%04:48 EDT
成交量:123.14万
成交额:2,347.22万
市值:30.29亿
市盈率:-6.68
高:19.62
开:19.33
低:18.90
收:19.45
52周最高:27.30
52周最低:13.75
股本:1.60亿
流通股本:1.51亿
量比:0.59
换手率:0.82%
股息:- -
股息率:- -
每股收益(TTM):-2.8353
每股收益(LYR):-2.9700
净资产收益率:-54.93%
总资产收益率:-29.15%
市净率:3.63
市盈率(LYR):-6.38

数据加载中...

2023/10/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/21

重要事件披露

Form 8-K - Current report
2023/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/08

重要事件披露

Form 8-K - Current report
2023/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities